Literature DB >> 27981469

Frontline Account: Reducing the Stress of Pain Management Through the Implementation of a Controlled Substance Review Group in a VA Internal Medicine Residency Clinic.

Claire Zeigler1,2, Katherine Mackey3,4, Elizabeth Hulen5, Thomas Carr3,4, Somnath Saha3,4,5, Samuel T Edwards3,4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27981469      PMCID： PMC5481221          DOI： 10.1007/s11606-016-3930-9

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  4 in total

1.  A comparison of methods of administering the opioid risk tool.

Authors:  Ted Jones; Steven D Passik
Journal:  J Opioid Manag       Date:  2011 Sep-Oct

2.  The DIRE score: predicting outcomes of opioid prescribing for chronic pain.

Authors:  Miles J Belgrade; Cassandra D Schamber; Bruce R Lindgren
Journal:  J Pain       Date:  2006-09       Impact factor: 5.820

3.  The patient-provider relationship in chronic pain care: providers' perspectives.

Authors:  Marianne S Matthias; Amy L Parpart; Kathryn A Nyland; Monica A Huffman; Dawana L Stubbs; Christy Sargent; Matthew J Bair
Journal:  Pain Med       Date:  2010-11       Impact factor: 3.750

4.  CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  MMWR Recomm Rep       Date:  2016-03-18
  4 in total
  2 in total

1.  Setting Expectations, Following Orders, Safety, and Standardization: Clinicians' Strategies to Guide Difficult Conversations About Opioid Prescribing.

Authors:  Jessica J Wyse; Linda Ganzini; Steven K Dobscha; Erin E Krebs; Benjamin J Morasco
Journal:  J Gen Intern Med       Date:  2019-04-22       Impact factor: 5.128

2.  Utilizing a Faculty Development Program to Promote Safer Opioid Prescribing for Chronic Pain in Internal Medicine Resident Practices.

Authors:  Payel Roy; Angela H Jackson; Jeffrey Baxter; Belle Brett; Michael Winter; Ilana Hardesty; Daniel P Alford
Journal:  Pain Med       Date:  2019-04-01       Impact factor: 3.750
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.